Advanced brain aging in Parkinson’s disease with cognitive impairment
Open Access
- 16 March 2024
- journal article
- research article
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 10 (1) , 1-11
Abstract
Patients with Parkinson’s disease and cognitive impairment (PD-CI) deteriorate faster than those without cognitive impairment (PD-NCI), suggesting an underlying difference in the neurodegeneration process. We aimed to verify brain age differences in PD-CI and PD-NCI and their clinical significance. A total of 94 participants (PD-CI, n = 27; PD-NCI, n = 34; controls, n = 33) were recruited. Predicted age difference (PAD) based on gray matter (GM) and white matter (WM) features were estimated to represent the degree of brain aging. Patients with PD-CI showed greater GM-PAD (7.08 ± 6.64 years) and WM-PAD (8.82 ± 7.69 years) than those with PD-NCI (GM: 1.97 ± 7.13, Padjusted = 0.011; WM: 4.87 ± 7.88, Padjusted = 0.049) and controls (GM: -0.58 ± 7.04, Padjusted = 0.004; WM: 0.88 ± 7.45, Padjusted = 0.002) after adjusting demographic factors. In patients with PD, GM-PAD was negatively correlated with MMSE (Padjusted = 0.011) and MoCA (Padjusted = 0.013) and positively correlated with UPDRS Part II (Padjusted = 0.036). WM-PAD was negatively correlated with logical memory of immediate and delayed recalls (Padjusted = 0.003 and Padjusted < 0.001). Also, altered brain regions in PD-CI were identified and significantly correlated with brain age measures, implicating the neuroanatomical underpinning of neurodegeneration in PD-CI. Moreover, the brain age metrics can improve the classification between PD-CI and PD-NCI. The findings suggest that patients with PD-CI had advanced brain aging that was associated with poor cognitive functions. The identified neuroimaging features and brain age measures can serve as potential biomarkers of PD-CI.Keywords
This publication has 43 references indexed in Scilit:
- Neuroimaging approaches to cognition in Parkinson's disease2022
- Global scales for cognitive screening in Parkinson's disease: Critique and recommendationsMovement Disorders, 2017
- Imaging synucleinopathiesMovement Disorders, 2016
- Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?Movement Disorders, 2015
- Automatic whole brain tract‐based analysis using predefined tracts in a diffusion spectrum imaging template and an accurate registration strategyHuman Brain Mapping, 2015
- Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damageHuman Brain Mapping, 2013
- DTI correlates of distinct cognitive impairments in Parkinson's diseaseHuman Brain Mapping, 2013
- Risk of dementia in an elderly population of Parkinson's disease patients: A 15‐year population‐based studyAlzheimer's & Dementia, 2012
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMovement Disorders, 2007